EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neutrophil‐Derived Biomimetic Nanoreactors Reprogram the Mitochondrial Metabolism‐Inflammation Axis to Alleviate Hepatic Ischemia‐Reperfusion Injury

Pu Shen, Mingbin Zhan, Kaijun Huang, Quanshi Lin, Shuting Xie, Renguo Guan iD, Haoxiang Yuan, Ye Lin iD, Xianwen Wang iD, Zhijin Fan iD

Advanced Science · 16.11.2026

DOI: 10.1002/advs.78722 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 16.11.2026. Verfasst von Pu Shen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Projects in Guangzhou, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic ischemia‐reperfusion injury (IRI) is a major cause of postoperative liver dysfunction after hepatectomy and liver transplantation; however, effective targeted therapies are unavailable. Here, we developed a biomimetic nanoplatform, Curcumin@CeO 2 @ZIF‐8@N2 neutrophil‐derived cellular vesicles (CCZ@N2‐CVs), for targeted and multimodal protection against hepatic IRI. ZIF‐8 enables acid‐responsive curcumin release and localized Zn 2 + delivery within the injury microenvironment, and CeO 2 provides sustained antioxidant activity via Ce 3 + /Ce 4 + redox cycling. Surface coating with N2 neutrophil‐derived vesicles endows the nanoplatform with inflammation‐targeting capabilities and intrinsic immunomodulatory properties. In hepatocytes subjected to hypoxia‐reoxygenation, CCZ@N2‐CVs markedly attenuate oxidative stress, inflammatory cytokine production, and apoptosis, and restore mitochondrial membrane potential, respiratory function, and ATP generation. Moreover, the platform suppresses pro‐inflammatory macrophage polarization and promotes a reparative phenotype, thereby enhancing hepatocyte proliferation and migration. In a rat hepatic IRI model, intravenously administered CCZ@N2‐CVs preferentially accumulate in the liver and significantly mitigate tissue injury, as evidenced by reduced serum alanine aminotransferase and aspartate aminotransferase levels, decreased apoptosis, and improved histopathological outcomes. Enhanced mitochondrial metabolism and suppressed inflammatory pathways are observed in a transcriptomic analysis. Furthermore, CCZ@N2‐CVs demonstrate favorable biosafety. Collectively, this biomimetic platform exhibits ion‐mediated therapeutic nanozyme activity and establishes targeted delivery to achieve multi‐mechanistic protection against hepatic IRI.

Schlagwörter

Stichwörter der Autor:innen

curcuminhepatic ischemia‐reperfusion injuryion‐therapeutic nanoplatformneutrophil‐derived cellular vesicles

Autor:innen und Institutionen

  • Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Spine Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Department of Hepatobiliary Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
  • Department of Clinical Laboratory, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Institute For Engineering Medicine, Kunming Medical University, Kunming, China.
  • Department of Thoracic Surgery and Oncology, State Key Laboratory of Respiratory Disease & National Clinical Research Center For Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangz…

ORCID-Profile: Renguo Guan, Ye Lin, Xianwen Wang, Zhijin Fan

Förderung

  • Science and Technology Projects in Guangzhou
  • National Natural Science Foundation of China

Zitieren

APA

Shen, P., Zhan, M., Huang, K., Lin, Q., Xie, S., Guan, R., Yuan, H., Lin, Y., Wang, X., & Fan, Z. (2026). Neutrophil‐Derived Biomimetic Nanoreactors Reprogram the Mitochondrial Metabolism‐Inflammation Axis to Alleviate Hepatic Ischemia‐Reperfusion Injury. Advanced Science. https://doi.org/10.1002/advs.78722

Vancouver

Shen P, Zhan M, Huang K, Lin Q, Xie S, Guan R, et al. Neutrophil‐Derived Biomimetic Nanoreactors Reprogram the Mitochondrial Metabolism‐Inflammation Axis to Alleviate Hepatic Ischemia‐Reperfusion Injury. Advanced Science. 2026. doi:10.1002/advs.78722

BibTeX
@article{Shen2026,
  author = {Shen, Pu and Zhan, Mingbin and Huang, Kaijun and Lin, Quanshi and Xie, Shuting and Guan, Renguo and Yuan, Haoxiang and Lin, Ye and Wang, Xianwen and Fan, Zhijin},
  title = {Neutrophil‐Derived Biomimetic Nanoreactors Reprogram the Mitochondrial Metabolism‐Inflammation Axis to Alleviate Hepatic Ischemia‐Reperfusion Injury},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.78722}
}
Kostenlos starten →